Jamison Private Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Jamison Private Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$201K	Buy	+405	New	+$179K	0.02%	222
2024 Q4	–	Sell	-5	Closed	-$2.33K	–	474
2024 Q3	$2.33K	Hold	5	–	–	﹤0.01%	419
2024 Q2	$2.34K	Hold	5	–	–	﹤0.01%	384
2024 Q1	$2.09K	Buy	+5	New	+$2.11K	﹤0.01%	396

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Jamison Private Wealth Management's VRTX Position: Q2 2026 in Review

Jamison Private Wealth Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 405 shares worth $201K. The stake represents 0.02% of the portfolio and ranks #222 among its holdings. This is a return to the name: Jamison Private Wealth Management previously reported a position in VRTX as recently as Q3 2024.

Jamison Private Wealth Management first reported a position in VRTX in Q1 2024 and has held it in 4 quarters since. 429 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Jamison Private Wealth Management held 405 shares of Vertex Pharmaceuticals worth $201K as of Q2 2026.
Vertex Pharmaceuticals was a new Jamison Private Wealth Management position in Q2 2026.
Vertex Pharmaceuticals made up 0.02% of Jamison Private Wealth Management's portfolio in Q2 2026, its #222 holding.
Jamison Private Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
429 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Jamison Private Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.